Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size, Status and Forecast 2021-2027

Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Filgrastim
1.2.3 Pefigrastim
1.2.4 Lipefigrastim
1.3 Market by Application
1.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Blood Disease
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Perspective (2016-2027)
2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Growth Trends by Regions
2.2.1 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Industry Dynamic
2.3.1 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Trends
2.3.2 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Drivers
2.3.3 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Challenges
2.3.4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Revenue
3.1.1 Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Revenue (2016-2021)
3.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue
3.4 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Concentration Ratio
3.4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue in 2020
3.5 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Key Players Head office and Area Served
3.6 Key Players Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Solution and Service
3.7 Date of Enter into Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Breakdown Data by Type
4.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Type (2022-2027)
5 Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Breakdown Data by Application
5.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
6.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
6.2.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
6.2.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
6.2.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
6.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
6.3.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
6.3.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
6.3.3 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
6.4 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
6.4.1 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
6.4.2 North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
7.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
7.2.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
7.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
7.3.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
7.4 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
7.4.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
8.2.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
8.3.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region
8.4.1 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
9.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
9.2.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
9.3 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
9.3.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
9.4 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
9.4.1 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type
10.2.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application
10.3.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country
10.4.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.1.4 Amgen Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Details
11.2.2 Kyowa Kirin Business Overview
11.2.3 Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.2.4 Kyowa Kirin Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.2.5 Kyowa Kirin Recent Development
11.3 Chugai Pharmaceutical
11.3.1 Chugai Pharmaceutical Company Details
11.3.2 Chugai Pharmaceutical Business Overview
11.3.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.3.4 Chugai Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.3.5 Chugai Pharmaceutical Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.4.4 Novartis Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.5.4 Teva Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.6.4 Pfizer Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.7.4 Merck Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Dong-A Socio
11.8.1 Dong-A Socio Company Details
11.8.2 Dong-A Socio Business Overview
11.8.3 Dong-A Socio Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.8.4 Dong-A Socio Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.8.5 Dong-A Socio Recent Development
11.9 Intas
11.9.1 Intas Company Details
11.9.2 Intas Business Overview
11.9.3 Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.9.4 Intas Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.9.5 Intas Recent Development
11.10 GenSci
11.10.1 GenSci Company Details
11.10.2 GenSci Business Overview
11.10.3 GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.10.4 GenSci Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.10.5 GenSci Recent Development
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.11.4 Dr. Reddy Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.11.5 Dr. Reddy Recent Development
11.12 Amoytop
11.12.1 Amoytop Company Details
11.12.2 Amoytop Business Overview
11.12.3 Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.12.4 Amoytop Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.12.5 Amoytop Recent Development
11.13 North China Pharmaceutical
11.13.1 North China Pharmaceutical Company Details
11.13.2 North China Pharmaceutical Business Overview
11.13.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.13.4 North China Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.13.5 North China Pharmaceutical Recent Development
11.14 SL Pharm
11.14.1 SL Pharm Company Details
11.14.2 SL Pharm Business Overview
11.14.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.14.4 SL Pharm Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.14.5 SL Pharm Recent Development
11.15 Hayao Group
11.15.1 Hayao Group Company Details
11.15.2 Hayao Group Business Overview
11.15.3 Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Introduction
11.15.4 Hayao Group Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021)
11.15.5 Hayao Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Filgrastim
Table 3. Key Players of Pefigrastim
Table 4. Key Players of Lipefigrastim
Table 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions (2016-2021)
Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions (2022-2027)
Table 11. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Trends
Table 12. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Drivers
Table 13. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Challenges
Table 14. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Restraints
Table 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Players (2016-2021)
Table 17. Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs as of 2020)
Table 18. Ranking of Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product Solution and Service
Table 22. Date of Enter into Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 65. Amgen Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Kyowa Kirin Company Details
Table 68. Kyowa Kirin Business Overview
Table 69. Kyowa Kirin Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 70. Kyowa Kirin Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 71. Kyowa Kirin Recent Development
Table 72. Chugai Pharmaceutical Company Details
Table 73. Chugai Pharmaceutical Business Overview
Table 74. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 75. Chugai Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 76. Chugai Pharmaceutical Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 80. Novartis Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 85. Teva Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 86. Teva Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 90. Pfizer Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 95. Merck Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Dong-A Socio Company Details
Table 98. Dong-A Socio Business Overview
Table 99. Dong-A Socio Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 100. Dong-A Socio Recent Development
Table 101. Intas Company Details
Table 102. Intas Business Overview
Table 103. Intas Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 104. Intas Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 105. Intas Recent Development
Table 106. GenSci Company Details
Table 107. GenSci Business Overview
Table 108. GenSci Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 109. GenSci Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 110. GenSci Recent Development
Table 111. Dr. Reddy Company Details
Table 112. Dr. Reddy Business Overview
Table 113. Dr. Reddy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 114. Dr. Reddy Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 115. Dr. Reddy Recent Development
Table 116. Amoytop Company Details
Table 117. Amoytop Business Overview
Table 118. Amoytop Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 119. Amoytop Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 120. Amoytop Recent Development
Table 121. North China Pharmaceutical Company Details
Table 122. North China Pharmaceutical Business Overview
Table 123. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 124. North China Pharmaceutical Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 125. North China Pharmaceutical Recent Development
Table 126. SL Pharm Company Details
Table 127. SL Pharm Business Overview
Table 128. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 129. SL Pharm Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 130. SL Pharm Recent Development
Table 131. Hayao Group Company Details
Table 132. Hayao Group Business Overview
Table 133. Hayao Group Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Product
Table 134. Hayao Group Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Business (2016-2021) & (US$ Million)
Table 135. Hayao Group Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Filgrastim Features
Figure 3. Pefigrastim Features
Figure 4. Lipefigrastim Features
Figure 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application: 2020 VS 2027
Figure 6. Oncology Case Studies
Figure 7. Blood Disease Case Studies
Figure 8. Other Case Studies
Figure 9. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Report Years Considered
Figure 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Regions (2022-2027)
Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Players in 2020
Figure 15. Global Top Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulocyte-Colony Stimulating Factor (G-CSF) Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue in 2020
Figure 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 21. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 22. North America Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Country (2016-2027)
Figure 23. United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 27. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Application (2016-2027)
Figure 28. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Country (2016-2027)
Figure 29. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Granulocyte-Colony Stimulat

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs